{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:09:31Z","timestamp":1792757371712,"version":"4.5.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,21]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Resistance to glucocorticoid treatment in pediatric T-ALL can be reversed by LCK inhibitors in vitro and in vivo. IL-4 overexpression contributes to LCK-induced glucocorticoid resistance.<\/jats:p>","DOI":"10.1182\/blood-2017-05-784603","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T15:15:47Z","timestamp":1509722147000},"page":"2750-2761","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":68,"title":["Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"130","author":[{"given":"Valentina","family":"Serafin","sequence":"first","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Capuzzo","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Milani","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Anna","family":"Minuzzo","sequence":"additional","affiliation":[{"name":"Immunology and Oncology Section, Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Pinazza","sequence":"additional","affiliation":[{"name":"Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, Padova, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bortolozzi","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bresolin","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Porc\u00f9","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Frasson","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"},{"name":"Immunology and Oncology Section, Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy;"},{"name":"Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, Padova, Italy; and"},{"name":"Istituto di Ricerca Pediatrica Citt\u00e0 della Speranza, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Indraccolo","sequence":"additional","affiliation":[{"name":"Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, Padova, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basso","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Accordi","sequence":"additional","affiliation":[{"name":"Department of Woman\u2019s and Child\u2019s Health and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111904461741500_B1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia","volume":"24","author":"Conter","year":"2010","journal-title":"Leukemia"},{"issue":"9","key":"2019111904461741500_B2","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1007\/s13277-014-1873-5","article-title":"The effect of TLX3 expression on the prognosis of pediatric T cell acute lymphocytic leukemia\u2014a systematic review","volume":"35","author":"Ma","year":"2014","journal-title":"Tumour Biol"},{"issue":"1","key":"2019111904461741500_B3","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.3324\/haematol.2014.112151","article-title":"Clinical features and outcome of SIL\/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group","volume":"100","author":"D\u2019Angi\u00f2","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"2019111904461741500_B4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exphem.2015.05.017","article-title":"Novel biological insights in T-cell acute lymphoblastic leukemia","volume":"43","author":"Durinck","year":"2015","journal-title":"Exp Hematol"},{"issue":"16","key":"2019111904461741500_B5","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111904461741500_B6","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","article-title":"Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study","volume":"118","author":"Schrappe","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111904461741500_B7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1535-6108(03)00086-2","article-title":"Protein microarrays: meeting analytical challenges for clinical applications","volume":"3","author":"Liotta","year":"2003","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111904461741500_B8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/14737159.7.5.625","article-title":"Reverse-phase protein microarrays: application to biomarker discovery and translational medicine","volume":"7","author":"VanMeter","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"2019111904461741500_B9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molonc.2010.09.003","article-title":"Reverse phase protein microarrays advance to use in clinical trials","volume":"4","author":"Mueller","year":"2010","journal-title":"Mol Oncol"},{"issue":"4","key":"2019111904461741500_B10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nri3403","article-title":"T cell receptor signalling networks: branched, diversified and bounded","volume":"13","author":"Brownlie","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2019111904461741500_B11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri2397","article-title":"Tailoring T-cell receptor signals by proximal negative feedback mechanisms","volume":"8","author":"Acuto","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"2019111904461741500_B12","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.18632\/oncotarget.2062","article-title":"Low PKC\u03b1 expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome","volume":"5","author":"Milani","year":"2014","journal-title":"Oncotarget"},{"issue":"10","key":"2019111904461741500_B13","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"7","key":"2019111904461741500_B14","first-page":"675","article-title":"New methodologic approaches for immunophenotyping acute leukemias","volume":"86","author":"Basso","year":"2001","journal-title":"Haematologica"},{"issue":"10","key":"2019111904461741500_B15","doi-asserted-by":"crossref","first-page":"e13552","DOI":"10.1371\/journal.pone.0013552","article-title":"Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL","volume":"5","author":"Accordi","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"2019111904461741500_B16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/leu.2017.13","article-title":"Phosphoproteomic analysis reveals hyperactivation of mTOR\/STAT3 and LCK\/calcineurin axes in pediatric early T-cell precursor ALL","volume":"31","author":"Serafin","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"2019111904461741500_B17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1189\/jlb.2AB0715-301R","article-title":"Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: focus on apoptotic proteins","volume":"100","author":"Frezzato","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2019111904461741500_B18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1078-0432.CCR-07-4175","article-title":"Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate","volume":"14","author":"Brave","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2019111904461741500_B19","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/cdd.2010.25","article-title":"Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia","volume":"17","author":"Harr","year":"2010","journal-title":"Cell Death Differ"},{"issue":"7","key":"2019111904461741500_B20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/14737140.2014.924400","article-title":"Bosutinib: a third generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia","volume":"14","author":"Hill","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"2019111904461741500_B21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/jm501562a","article-title":"Nintedanib: from discovery to the clinic","volume":"58","author":"Roth","year":"2015","journal-title":"J Med Chem"},{"issue":"3","key":"2019111904461741500_B22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.18632\/oncotarget.2807","article-title":"LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients","volume":"6","author":"Cazzaniga","year":"2015","journal-title":"Oncotarget"},{"issue":"16","key":"2019111904461741500_B23","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1021\/jm060435i","article-title":"Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity","volume":"49","author":"Martin","year":"2006","journal-title":"J Med Chem"},{"issue":"2","key":"2019111904461741500_B24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/leu.2013.183","article-title":"Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts","volume":"28","author":"Agnusdei","year":"2014","journal-title":"Leukemia"},{"issue":"31","key":"2019111904461741500_B25","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1200\/JCO.2008.20.8934","article-title":"Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow","volume":"27","author":"Basso","year":"2009","journal-title":"J Clin Oncol"},{"key":"2019111904461741500_B26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"issue":"3","key":"2019111904461741500_B27","doi-asserted-by":"crossref","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"9","key":"2019111904461741500_B28","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1158\/0008-5472.CAN-06-4244","article-title":"Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia","volume":"67","author":"Bachmann","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"2019111904461741500_B29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3640","article-title":"Recruitment of calcineurin to the TCR positively regulates T cell activation","volume":"18","author":"Dutta","year":"2017","journal-title":"Nat Immunol"},{"issue":"15","key":"2019111904461741500_B30","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111904461741500_B31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family: regulation and function","volume":"15","author":"Rao","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2019111904461741500_B32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/jimmunol.149.1.107","article-title":"IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis","volume":"149","author":"Zubiaga","year":"1992","journal-title":"J Immunol"},{"issue":"7","key":"2019111904461741500_B33","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.151.7.3460","article-title":"Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids","volume":"151","author":"Kam","year":"1993","journal-title":"J Immunol"},{"issue":"1","key":"2019111904461741500_B34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.181.1.33","article-title":"Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma","volume":"181","author":"Leung","year":"1995","journal-title":"J Exp Med"},{"issue":"10","key":"2019111904461741500_B35","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.4049\/jimmunol.1601029","article-title":"Cytokine-induced glucocorticoid resistance from eosinophil activation: protein phosphatase 5 modulation of glucocorticoid receptor phosphorylation and signaling","volume":"197","author":"Pazdrak","year":"2016","journal-title":"J Immunol"},{"issue":"12","key":"2019111904461741500_B36","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/sj.bjc.6605072","article-title":"Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism","volume":"100","author":"Beesley","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"2019111904461741500_B37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bjh.12727","article-title":"Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia","volume":"165","author":"Samuels","year":"2014","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111904461741500_B38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","article-title":"Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia","volume":"24","author":"Piovan","year":"2013","journal-title":"Cancer Cell"},{"issue":"6212","key":"2019111904461741500_B39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/338257a0","article-title":"Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck","volume":"338","author":"Veillette","year":"1989","journal-title":"Nature"},{"issue":"2","key":"2019111904461741500_B40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(94)90335-2","article-title":"Signals and signs for lymphocyte responses","volume":"76","author":"Janeway","year":"1994","journal-title":"Cell"},{"issue":"6608","key":"2019111904461741500_B41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/384484a0","article-title":"Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation","volume":"384","author":"Yamaguchi","year":"1996","journal-title":"Nature"},{"issue":"48","key":"2019111904461741500_B42","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1038\/sj.onc.1208081","article-title":"Structure and regulation of Src family kinases","volume":"23","author":"Boggon","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"2019111904461741500_B43","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2004-12-4790","article-title":"Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn","volume":"106","author":"L\u00f6wenberg","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111904461741500_B44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.embor.7400775","article-title":"Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN","volume":"7","author":"L\u00f6wenberg","year":"2006","journal-title":"EMBO Rep"},{"issue":"4","key":"2019111904461741500_B45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molmed.2007.02.001","article-title":"Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression","volume":"13","author":"L\u00f6wenberg","year":"2007","journal-title":"Trends Mol Med"},{"issue":"2","key":"2019111904461741500_B46","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2352-3026(15)00254-9","article-title":"Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis","volume":"3","author":"Conter","year":"2016","journal-title":"Lancet Haematol"},{"issue":"1","key":"2019111904461741500_B47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3324\/haematol.2013.088674","article-title":"NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins","volume":"99","author":"De Keersmaecker","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"2019111904461741500_B48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1074-7613(04)00052-4","article-title":"Calcineurin B1 is essential for positive but not negative selection during thymocyte development","volume":"20","author":"Neilson","year":"2004","journal-title":"Immunity"},{"issue":"6","key":"2019111904461741500_B49","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm1588","article-title":"Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia","volume":"13","author":"Medyouf","year":"2007","journal-title":"Nat Med"},{"issue":"2","key":"2019111904461741500_B50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ceca.2007.03.007","article-title":"Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes","volume":"42","author":"Gwack","year":"2007","journal-title":"Cell Calcium"},{"issue":"1","key":"2019111904461741500_B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)13074-3","article-title":"Activation and deactivation of gene expression by Ca2+\/calcineurin-NFAT-mediated signaling","volume":"18","author":"Im","year":"2004","journal-title":"Mol Cells"},{"issue":"3","key":"2019111904461741500_B52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/cc.7.3.5357","article-title":"The calcineurin\/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors","volume":"7","author":"Medyouf","year":"2008","journal-title":"Cell Cycle"},{"issue":"2","key":"2019111904461741500_B53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1165\/rcmb.2007-0327OC","article-title":"IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance","volume":"40","author":"Goleva","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"2019111904461741500_B54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"issue":"7","key":"2019111904461741500_B55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ncb816","article-title":"The role of NFAT transcription factors in integrin-mediated carcinoma invasion","volume":"4","author":"Jauliac","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"12","key":"2019111904461741500_B56","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2005-03-1167","article-title":"Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival","volume":"106","author":"Pham","year":"2005","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/25\/2750\/1404222\/blood784603.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/25\/2750\/1404222\/blood784603.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T08:08:26Z","timestamp":1719562106000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/25\/2750\/36875\/Glucocorticoid-resistance-is-reverted-by-LCK"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":56,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,12,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-05-784603","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}